oxycodone has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Collins, M; Conway, B; Dylla, DE; Khan, T; Marcinak, J; Martinez, A; Saget, B | 1 |
Beheshti, D | 1 |
Alpert, A; Pacula, RL; Powell, D | 2 |
Bigal, ME | 1 |
Havens, JR; Stephens, DB | 1 |
Okon, T | 1 |
Lake, JR; Lucey, MR | 1 |
2 review(s) available for oxycodone and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Abuse-Deterrent OxyContin And Hepatitis C.
Topics: Adult; Antiviral Agents; Disease Progression; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Opioid-Related Disorders; Oxycodone; Risk Assessment; Severity of Illness Index; Substance-Related Disorders | 2019 |
Ketamine: an introduction for the pain and palliative medicine physician.
Topics: Adult; Amines; Analgesics; Analgesics, Opioid; Central Nervous System; Cryoglobulinemia; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hepatitis C; Humans; Ketamine; Methadone; Methylphenidate; Oxycodone; Pain, Intractable; Receptors, N-Methyl-D-Aspartate; Treatment Outcome; Ulcer; Vasculitis | 2007 |
6 other study(ies) available for oxycodone and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.
Topics: Analgesics, Opioid; Antiviral Agents; Fentanyl; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Hydrocodone; Oxycodone; Sofosbuvir | 2023 |
Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin.
Topics: Analgesics, Opioid; Drug Administration Routes; Drug Overdose; Hepatitis A; Hepatitis B; Hepatitis C; Heroin; HIV Infections; Humans; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; Substance Abuse, Intravenous; Technology, Pharmaceutical; United States | 2019 |
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C.
Topics: Analgesics, Opioid; Hepacivirus; Hepatitis C; Humans; Illicit Drugs; Injections, Intravenous; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse; United States | 2019 |
Abuse-Deterrent Opioids: The Authors Reply.
Topics: Analgesics, Opioid; Chronic Pain; Hepatitis C; Humans; Opioid-Related Disorders; Oxycodone | 2019 |
Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.
Topics: Adult; Alcohol Drinking; Appalachian Region; Counseling; Disclosure; Female; Follow-Up Studies; Hepatitis C; Humans; Longitudinal Studies; Male; Marijuana Abuse; Multivariate Analysis; Oxycodone; Prospective Studies; Regression Analysis; Rural Population; Substance-Related Disorders; Surveys and Questionnaires | 2013 |
The challenging patient: HCV and alcoholic liver disease.
Topics: Back Pain; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Inflammation; Lactulose; Liver; Liver Diseases, Alcoholic; Liver Transplantation; Male; Middle Aged; Oxycodone | 2007 |